Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile
Authors:
- Ching-Ling ChengCCChing-Ling Cheng
- Guei-Jen KangGKGuei-Jen Kang
- Chen-Hsi ChouCCChen-Hsi Chou
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1154 (1-2) , 222-229
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography–electrospray ionization tandem mass spectrometryJournal of Chromatography A, 2006
- The Clinical Pharmacokinetics of Phosphodiesterase‐5 Inhibitors for Erectile DysfunctionThe Journal of Clinical Pharmacology, 2005
- Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detectionJournal of Chromatography B, 2005
- Determination of Vardenafil in Pharmaceutical Formulation by HPLC Using Conventional C18 and Monolithic Silica ColumnsJournal of Liquid Chromatography & Related Technologies, 2005
- Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunctionNature Reviews Endocrinology, 2005
- Simultaneous determination of sildenafil, vardenafil and tadalafil as forbidden components in natural dietary supplements for male sexual potency by high-performance liquid chromatography–electrospray ionization mass spectrometryJournal of Chromatography A, 2005
- Development of a Micellar electrokinetic capillary chromatography method for the determination of three drugs employed in the erectile dysfunction therapyJournal of Chromatography B, 2004
- Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC–ESI–MS and LC–UVJournal of Pharmaceutical and Biomedical Analysis, 2004
- Effect of High‐Fat Breakfast and Moderate‐Fat Evening Meal on the Pharmacokinetics of Vardenafil, an Oral Phosphodiesterase‐5 Inhibitor for the Treatment of Erectile DysfunctionThe Journal of Clinical Pharmacology, 2003
- VardenafilDrugs & Aging, 2002